title: [Target Molecule for a Demyelinating Type of Guillain-Barré Syndrome, Acute Inflammatory Demyelinating Polyneuropathy].
abstract: Guillain-Barré syndrome is classified into demyelinating type, acute inflammatory demyelinating polyneuropathy (AIDP) and axonal form, acute axonal motor neuropathy (AMAN). It has been clearly established that the target molecule for the former is a ganglioside. In contrast, despite years of effort, the target molecule for the latter has not been identified. Recently, molecules around the nodes of Ranvier have entered the spotlight, and "moesin" was reported to be a target molecule for cytomegalovirus associated-AIDP.
authors.affiliation: Department of Neurology, Graduate School of Medicine, Chiba University.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Mori
mesh_terms: D000818:Animals; D000906:Antibodies / Q000378:metabolism; D001369:Axons / Q000378:metabolism*; D020275:Guillain-Barre Syndrome / Q000175:diagnosis / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism*; D009186:Myelin Sheath / Q000276:immunology* / Q000473:pathology
chemical_list: D000906:Antibodies; D007074:Immunoglobulin G